PMC:7279430 / 348-534 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"43","span":{"begin":167,"end":171},"obj":"Gene"},{"id":"50","span":{"begin":32,"end":42},"obj":"Species"},{"id":"51","span":{"begin":130,"end":140},"obj":"Species"},{"id":"52","span":{"begin":156,"end":166},"obj":"Species"},{"id":"53","span":{"begin":174,"end":184},"obj":"Species"}],"attributes":[{"id":"A43","pred":"tao:has_database_id","subj":"43","obj":"Gene:8673700"},{"id":"A50","pred":"tao:has_database_id","subj":"50","obj":"Tax:2697049"},{"id":"A51","pred":"tao:has_database_id","subj":"51","obj":"Tax:2697049"},{"id":"A52","pred":"tao:has_database_id","subj":"52","obj":"Tax:2697049"},{"id":"A53","pred":"tao:has_database_id","subj":"53","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"iratory syndrome coronavirus 2 (SARS-CoV-2). A molecular docking analysis was carried out using 171 essential oil components with SARS-CoV-2 main protease (SARS-CoV-2 Mpro), SARS-CoV-2 e"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T5","span":{"begin":32,"end":40},"obj":"Disease"},{"id":"T6","span":{"begin":130,"end":138},"obj":"Disease"},{"id":"T7","span":{"begin":156,"end":164},"obj":"Disease"},{"id":"T8","span":{"begin":174,"end":182},"obj":"Disease"}],"attributes":[{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"iratory syndrome coronavirus 2 (SARS-CoV-2). A molecular docking analysis was carried out using 171 essential oil components with SARS-CoV-2 main protease (SARS-CoV-2 Mpro), SARS-CoV-2 e"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T2","span":{"begin":45,"end":46},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"iratory syndrome coronavirus 2 (SARS-CoV-2). A molecular docking analysis was carried out using 171 essential oil components with SARS-CoV-2 main protease (SARS-CoV-2 Mpro), SARS-CoV-2 e"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T5","span":{"begin":100,"end":124},"obj":"Chemical"},{"id":"T6","span":{"begin":100,"end":113},"obj":"Chemical"}],"attributes":[{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_27311"},{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_83630"}],"text":"iratory syndrome coronavirus 2 (SARS-CoV-2). A molecular docking analysis was carried out using 171 essential oil components with SARS-CoV-2 main protease (SARS-CoV-2 Mpro), SARS-CoV-2 e"}